Proline

Proline

SCHEMBL5144381

NC(=O)[C@@H](N)CS.NCC(=O)O.N[C@@H](CS)C(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.41
SLC7A11 Q9UPY5 1/20 0.41
NOS2 P35228 2/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
CPN1 P15169 3/20 0.33
CPB2 Q96IY4 3/20 0.33
GLI1 P08151 1/20 0.33
DPP4 P27487 1/20 0.30
DPP8 Q6V1X1 1/20 0.30
DPP9 Q86TI2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL4398351 0.95 PTGS1 (0.46) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL28870346 0.95 PTGS1 (0.46) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL3489758 0.95 PTGS1 (0.46) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL28149498 0.95 PTGS1 (0.46) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL3103208 0.95 PTGS1 (0.46) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL1675268 0.95 PTGS1 (0.46) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL27998796 0.95 PTGS1 (0.46) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL1298202 0.89 PTGS1 (0.52) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL15050063 0.89 PTGS1 (0.52) PTGS1SLC7A11NOS2NOS3NOS1
Proline SCHEMBL51269 0.89 PTGS1 (0.52) PTGS1SLC7A11NOS2NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1333809-A4 MULTI-COMPONENT ANTIOXIDANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR REDUCING OR PREVENTING OXIDATIVE STRESS YISSUM RES DEV CO (IL) 2007-09-26 EP disclosed
EP-1333809-A2 MULTI-COMPONENT ANTIOXIDANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR REDUCING OR PREVENTING OXIDATIVE STRESS Yissum Research Development Company of the Hebrew University of Jerusalem (IL) 2003-08-13 EP disclosed
WO-2002034202-A2 MULTI-COMPONENT ANTIOXIDANT COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR REDUCING OR PREVENTING OXIDATIVE STRESS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2002-05-02 WO disclosed